Cargando…

Proceedings: Hormones and the prostate.

Detalles Bibliográficos
Autor principal:	Griffiths, K.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1974
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2009279/ https://www.ncbi.nlm.nih.gov/pubmed/4419386

Ejemplares similares

Proceedings: Hormones in breast cancer patients on tamoxifen.
por: Golder, M. P., et al.
Publicado: (1975)

Proceedings: The value of hormone measurements in tumour management.
por: Bagshawe, K. D.
Publicado: (1974)

Proceedings: Assay of steroid hormone receptor in cancers, methodology and perspectives.
por: Wagner, R. K., et al.
Publicado: (1974)

Proceedings of the 1992 Laurentian Hormone Conference /
Publicado: (1994)

Recent Progress in Hormone Research. The Proceedings of the 1954 Laurentian Hormone Conference
por: Forbes, Thomas R.
Publicado: (1955)

Proceedings: Prediction of response to antihormone treatment using an in vitro test for dependence of hormones.
por: Salih, H., et al.
Publicado: (1974)

Proceedings: The use of tissue culture in the screening of hormone sensitivity of endometrial carcinoma.
por: Hustin, J.
Publicado: (1974)

Parathyroid hormone is associated with prostate cancer
por: Kim, Won Tae, et al.
Publicado: (2020)

Cancer of the prostate: early diagnosis by zinc and hormone analysis?
por: Habib, F. K., et al.
Publicado: (1979)

Inhibition of in vivo proliferation of androgen-independent prostate cancers by an antagonist of growth hormone-releasing hormone.
por: Jungwirth, A., et al.
Publicado: (1997)

Addressing Cardiovascular Risk of Prostate Cancer Hormonal Therapy
por: Ryan, Charles J., et al.
Publicado: (2020)

Pathogenesis of prostate cancer and hormone refractory prostate cancer
por: Girling, J. S., et al.
Publicado: (2007)

Proceedings: Vaginal cytologic evaluation as a predictive test on hormone dependency and responsiveness to progestogens of endometrial adenocarcinoma.
por: Ide, P., et al.
Publicado: (1974)

The prognostic significance of prostate specific antigen in metastatic hormone-resistant prostate cancer.
por: Fosså, S. D., et al.
Publicado: (1992)

Hormones and prostate carcinogenesis: Androgens and estrogens
por: Bosland, Maarten C., et al.
Publicado: (2011)

Hormonal therapy and chemotherapy in hormone-naive and castration resistant prostate cancer
por: Recine, Federica, et al.
Publicado: (2015)

Proceedings: Human tumour cells in short term monolayer culture-cell cycle kinetics and effect of hormonal stimulation.
por: Lloyd, M. E., et al.
Publicado: (1975)

Changes in phospholipid metabolism in exosomes of hormone-sensitive and hormone-resistant prostate cancer cells
por: Yi, Xianlin, et al.
Publicado: (2021)

Debate on Treating Oligometastatic Metastatic Hormone-sensitive Prostate Cancer: The Argument for New-generation Hormone Therapy and Radiation Therapy to the Prostate
por: Saad, Fred
Publicado: (2022)

Steroid hormone synthetic pathways in prostate cancer
por: Mostaghel, Elahe A.
Publicado: (2013)

Hormone Excretion in Prostatic Cancer: An Attempt to Correlate Urinary Hormone Excretion and Clinical State
por: Bulbrook, R. D., et al.
Publicado: (1959)

Prostate radiotherapy for metastatic hormone sensitive prostate cancer—myth or reality?
por: Onal, Cem
Publicado: (2019)

The current status of scientific research and hormonal treatments for carcinoma of the prostate.
por: Waxman, J., et al.
Publicado: (1991)

Cardiovascular effects of hormone therapy for prostate cancer
por: Lester, Jason F, et al.
Publicado: (2015)

Leptomeningeal Metastases in Hormone Refractory Prostate Cancer
por: Ng, Jessica Y, et al.
Publicado: (2018)

Induction of transforming growth factor beta in hormonally treated human prostate cancer.
por: Muir, G. H., et al.
Publicado: (1994)

Adults in private family law proceedings in Wales: characteristics and vulnerabilities.
por: Cusworth, Linda, et al.
Publicado: (2022)

Proceedings of the 1(st) Biennial Science of Global Prostate Cancer Disparities in Black Men
por: Odedina, Folakemi T, et al.
Publicado: (2011)

Morphological and functional alterations of the prostate tissue during clinical progression in hormonally-naïve, hormonally-treated and castration-resistant patients with metastatic prostate cancer
por: Korček, Michal, et al.
Publicado: (2020)

Effects of a luteinizing hormone-releasing hormone agonist on cognitive, sexual, and hormonal functions in patients with prostate cancer: relationship with testicular and adrenal androgen levels
por: Okamoto, Kohei, et al.
Publicado: (2015)

Local prostate cancer radiotherapy after prostate-specific antigen progression during primary hormonal therapy
por: Pinkawa, Michael, et al.
Publicado: (2012)

Development of an immunotherapeutic adenovirus targeting hormone-independent prostate cancer
por: Kim, Jae Sik, et al.
Publicado: (2013)

Redefining Hormone Sensitive Disease in Advanced Prostate Cancer
por: Hou, Xiaoyu, et al.
Publicado: (2012)

Surgery and hormonal treatment for prostate cancer and sexual function
por: Canalichio, Katie, et al.
Publicado: (2015)

Proceedings of the NATO Advanced Research Workshop on Activation of Hormone and Growth Factor Receptors : Molecular Mechanisms and Consequences
por: Alexis, Michael, et al.
Publicado: (1990)

Liver Microenvironment Response to Prostate Cancer Metastasis and Hormonal Therapy
por: Buxton, Alison K., et al.
Publicado: (2022)

TITAN trial; shifting focus from hormone-refractory to hormone-sensitive prostate cancer
por: Kumar, Gautam
Publicado: (2020)

Combination Effects of Docetaxel and Doxorubicin in Hormone-Refractory Prostate Cancer Cells
por: Tsakalozou, Eleftheria, et al.
Publicado: (2012)

Prevalence study of intermittent hormonal therapy of Prostate Cancer patients in Spain
por: Bonfill-Cosp, Xavier, et al.
Publicado: (2022)

Increased MYBL2 expression in aggressive hormone‐sensitive prostate cancer
por: Yoshikawa, Yuki, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_7vq3eokne7evts3qg3jf18m5sf